Viewport Meta

IPhone / Mobile Compatible

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

DNSSEC

Content Delivery Network

WordPress

Global Site Tag

Chief Strategy Officer

Atul Deshpande

Healthcare

David Huang

Founder | President | CEO

Jonathan Steckbeck

Chief Technology Officer

Nicholas Nystrom

Business Management

Nick Pachuda

Human Resources

Albert Fonticiella

VP, CMC and Technical Operations

Bradd Picone

Vice President Program Development

Dessie Dobbins

SVP Platform and Technology

Francis Lee

Dietrich Stephan

Jason Camm

Catherine Mott

Fabian Hansen

Rick Oleson

Nicholas A. Nystrom

Ron Montelaro

Co-Founder

Co-Founder, President and CEO

Director

Nicholas Pachuda

Chief Operating Officer

Marc Lesnick

Sr. Vice President, Regulatory Affairs and Quality

United States Early Stage Companies (Top 10K)

Pennsylvania Startups Founded in 2013

United States Companies With Fewer Than 50 Employees (Top 10K)

United States Early Stage Companies With Less Than $1M in Revenue

Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.

Cystic Fibrosis Foundation

Grant - Peptilogics

Presight Capital

Series B - Peptilogics

Venture Round - Peptilogics

Series A - Peptilogics

Seed Round - Peptilogics

Convertible Note - Peptilogics

Pittsburgh

Pennsylvania

United States

North America

Peptilogics

COhatch has officially launched its SouthSide Works ...

The company landscape for artificial intelligence in large ...

Technology-enabled Drug Discovery Research Report 2023 ...

Peptilogics Completes Phase 1b Trial Enrollment and Will...

Peptilogics Announces First Patient Dosed in Phase 1b Study of PLG0206 for

EpiAxis Therapeutics & Peptilogics Enter Strategic Drug Discovery Partnership

Peptilogics names 2 to executive ranks

Peptilogics Strengthens Leadership Team with Executive Appointments

Peptilogics to Participate in Musculoskeletal Infection S...

Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target

An investigational antibiotic peptide candidate for treating periprosthetic joint infection, currently in clinical trial.

A computational platform utilizing AI for peptide drug discovery, designed to predict peptide design across various targets.

A policy outlining access to investigational drugs for patients not qualifying for clinical trials, under specific conditions.

Germany

Europe

HTML5

jQuery

Google Analytics

Google Fonts

Google Compute Engine

Adobe Fonts

GreenSock Animation Platform

Gravity Forms

Vimeo

Office 365

Peptilogics is a biotechnology company focused on revolutionizing the discovery process for novel peptide therapeutics to help patients with serious and life-threatening diseases. They explore untapped chemical space to engineer peptides to treat challenging diseases.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 6, 2024 5:19 PM	b70ecf0e
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 6, 2024 5:19 PM	bc3b5cbf
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	7a20d7d0
crunchbase profile	general	Nov 25, 2024 9:41 AM	512f26c5
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 1:54 PM	af69f491
peers	general
news basic	general	Mar 6, 2024 5:19 PM	59ed4936
bundesanzeiger	filings
financials download nd	financials
private financials	financials

PEPT

COM:PEPTILOGICS

Peptilogics